5002882026-08-065002882026-08-062026-08-065002882026-08-06in-capmkt:FinancialYear1Member5002882026-08-06in-capmkt:FinancialYear2Member5002882026-08-06in-capmkt:FinancialYear3Member5002882026-08-062026-08-06in-capmkt:FinancialYear1Member5002882026-08-062026-08-06in-capmkt:FinancialYear2Member5002882026-08-062026-08-06in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure500288MOREPEN LABORATORIES LIMITEDMOREPENLABNOTLISTEDINE083A01026NewAcquisition (including agreement to acquire)true2026-08-0615:00:002026-08-06Morepen Laboratories LimitedListed Entity (self)Morepen RX Limited (MRX)545000000-128000004800000falsetrueMRX is a wholly owned subsidiary and a related party of the company. Mr. Sanjay Suri, Mr. Varun Suri and Ms. Shalu Suri members of promoter group of the company are also the Directors of MRX. Except as stated above, none of the promoter(s), promoter group or group companies has any other interest in MRX.truePharmaceuticalSubscription to the rights issue of MRX to strengthen its capital base and support its business operationsNAfalseNot applicableCash200000000Acquisition of 2,00,00,000 (Two Crore) equity shares of Rs. 10/- each, at par, in the rights issue of MRX.2000000001MRX is engaged in the business of sales and marketing of Branded Prescription ("Rx") products.2023-03-172025-20265450000002024-202511276000002023-2024838300000IndiaThe company continues to hold 100% of the equity share capital of MRX.